Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
Launched by WEST CHINA SECOND UNIVERSITY HOSPITAL · Oct 11, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with cardiovascular disease, including Kawasaki disease, anomalous origin of coronary artery, postoperative congenital heart disease.
- Exclusion Criteria:
- • Mental abnormalities or poor compliance ; heart, kidney and other important organs were seriously incomplete.
- • MRI examination contraindications ; gadolinium contrast agent contraindications ; claustrophobia.
About West China Second University Hospital
West China Second University Hospital, affiliated with Sichuan University, is a leading medical institution in China renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, the hospital fosters an environment that integrates patient care, education, and scientific inquiry. Its comprehensive facilities and expertise in various medical fields enable the hospital to conduct high-quality clinical trials aimed at improving treatment outcomes and enhancing the overall understanding of complex diseases. The hospital is dedicated to ethical research practices and strives to contribute to the global medical community through its findings and advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported